恒瑞医药:公司将继续坚持科技创新与国际化发展战略,促进公司业绩可持续增长
Zheng Quan Ri Bao·2026-02-11 12:36

Core Viewpoint - Heng Rui Medicine emphasizes its commitment to technological innovation and international development strategies to ensure sustainable growth and better returns for shareholders [1] Group 1 - The company is actively pursuing a share buyback program as per its established plan [1]

Hengrui Pharma-恒瑞医药:公司将继续坚持科技创新与国际化发展战略,促进公司业绩可持续增长 - Reportify